Chen, Yiying
Gao, Yufeng
Wang, Haixia
Li, Weiqian
Zhou, Fanqi
Sun, Hao
Yu, Jia
Zou, Dongling
Wang, Fang
Article History
Received: 11 September 2025
Accepted: 31 March 2026
First Online: 11 April 2026
Declarations
:
: All clinical patients enrolled in this study provided written informed consent prior to participation. The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics board of Chongqing University Cancer Hospital (Approval No. CZLS2020217-A), as well as the Cancer Institute and the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Approval No. SB2024034 and ZS2025024, respectively). All animal experiments were approved by the institutional ethics committee (Approval No. ACUC-XM5B-2025-163) and performed in compliance with the principles of the 3Rs (Replacement, Reduction, and Refinement).
: Not applicable.
: The authors declare no competing interests.